Press Releases

    • FEB 10 2015

    Oncoceutics to Present at the Leerink Global Healthcare Conference

    Hummelstown, PA (February 9, 2015) – Oncoceutics, Inc., a drug discovery and development company targeting the most potent suppressor pathways in human cancer, announced today that Wolfgang Oster, M.D., Ph.D., Chief Executive Officer, will present a corporate overview at the 2015 Leerink Global Healthcare Conference on Thursday, February 12, 2015, at 1:25 pm ET, at

    • JAN 06 2015

    Novel anti-cancer drug, ONC201, focus of alliance between Oncoceutics and MD Anderson Cancer Center

    Hummelstown, PA (January 5, 2015) – Oncoceutics Inc. and The University of Texas MD Anderson Cancer Center today announced the initiation of a strategic alliance and research collaboration agreement for the clinical development of ONC201, a novel anti-cancer drug. Earlier preclinical studies of ONC201 have indicated there is merit in further investigation of the drug,